Transition report pursuant to Rule 13a-10 or 15d-10

Document and Entity Information

Document and Entity Information - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2018
Jun. 15, 2018
Jun. 30, 2017
Document And Entity Information      
Entity Registrant Name AIT Therapeutics, Inc.    
Entity Central Index Key 0001641631    
Document Type 10-KT    
Document Period End Date Mar. 31, 2018    
Amendment Flag false    
Current Fiscal Year End Date --03-31    
Entity a Well-known Seasoned Issuer No    
Entity a Voluntary Filer No    
Entity's Reporting Status Current Yes    
Entity Filer Category Smaller Reporting Company    
Entity Public Float     $ 0
Entity Common Stock, Shares Outstanding   8,406,657  
Trading Symbol AITB    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2018